Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Vascular Endothelial Growth Factor Receptor- 3
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Most Relevant Literature
- The pathological roles and potential mechanisms of vascular endothelial growth factor receptor-3 in …
- Morphometric image analysis of vascular endothelial growth factor receptor-3 in preeclamptic, HIV in…
- Investigation of Targeting Relationship between Micro-Rna-22 and Vegfr3 in Lung Squamous Cell Carcin…
- Primary Preclinical and Clinical Evaluation of 68Ga-DOTA-TMVP1 as a Novel VEGFR-3 PET Imaging Radiot…
- VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Most Relevant Clinical Trials
- Use of Pan-Vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Reti…
- Proteomics and Stem Cell Therapy as a New Vascularization Strategy
- Endothelial Progenitor Cells-capture Stents in Acute Coronary Syndromes
- Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula
- Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative …
